Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shilpa Medicare
Asia
Daiichi Sankyo, Clover, Insilico and more—Fierce Pharma Asia
Daiichi hires new R&D lead from Kite. Clover Biopharma nets $230 million series. Insilico touts several industry firsts for AI drug discovery.
Angus Liu
Feb 26, 2021 9:40am
FDA slaps import alert on Shilpa's Indian formulation plant
Feb 19, 2021 9:41am
FDA blasts Indian drugmaker for sterile injectables complaints
Oct 28, 2020 10:30am